The future is bright with AI-powered innovations, but migration presents significant risks, including data loss, increased costs, and disruption to business operations.
Derek Choy
Advertisement
Derek Choy is Co-founder and Chief Product Officer of Aktana
Articles by Derek Choy
Digital engagement is becoming the new normal, but it can inhibit the individual connection that is foundational to building long-term customer relationships. How can reps, brand teams, and medical science liaisons strike the right balance of personal and non-personal engagement? The next generation of AI has an answer, writes Derek Choy.
A crisis like COVID-19 is not one event, but many interconnected crises. If we’re not constantly learning and adapting, we’re going to be facing a long, painful recovery. We need to modernize how we operate, writes Derek Choy.
Advertisement
Latest Updated Articles
Future-Proofing CRM Investments in Life Sciences: Observations from Dreamforce 2024Published: January 8th 2025 | Updated:
- Post-COVID World Demands More Than AI
Published: June 15th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
3
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
4
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
5
